Royce Global Trust, a closed-end fund managed by Royce & Associates, focuses on long-term capital growth by investing primarily in small- and mid-cap global equities. As of September 30, 2026, the fund's net asset value (NAV) was $17.02 with a market price of $14.24, showing a one-year NAV return of 14.91%. The fund diversifies across sectors like Industrials, Financials, and Information Technology, and invests at least 65% of assets outside the U.S. Investors should note the risks associated with small- and mid-cap stocks and foreign investments. Daily NAVs are available online for transparency.
Royce Global Trust as of September 30, 2026, provides context for readers interested in financial markets. For readers following Financials-sector US stocks on Pluang, here is the market snapshot as of October 28, 2026, 23:02 WIB: Of 142 priced stocks, 65 rose and 72 fell. Notable movers include PURR at USD 9.50 with a 1-day change of -3.46% and 100% buy order activity, SOFI at USD 16.87 with a 1-day change of +2.87% and 41% buy order activity, and ACGL at USD 103.18 with a 1-day change of +2.83%.
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
